289 related articles for article (PubMed ID: 33434155)
1. ENDOCRINOLOGY IN PREGNANCY: Metabolic impact of bile acids in gestation.
Fan HM; Mitchell AL; Williamson C
Eur J Endocrinol; 2021 Mar; 184(3):R69-R83. PubMed ID: 33434155
[TBL] [Abstract][Full Text] [Related]
2. Maternal glucose homeostasis is impaired in mouse models of gestational cholestasis.
Bellafante E; McIlvride S; Nikolova V; Fan HM; Manna LB; Chambers J; Machirori M; Banerjee A; Murphy K; Martineau M; Schoonjans K; Marschall HU; Jones P; Williamson C
Sci Rep; 2020 Jul; 10(1):11523. PubMed ID: 32661285
[TBL] [Abstract][Full Text] [Related]
3. Bile acids and gestation.
McIlvride S; Dixon PH; Williamson C
Mol Aspects Med; 2017 Aug; 56():90-100. PubMed ID: 28506676
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype.
Abu-Hayyeh S; Papacleovoulou G; Lövgren-Sandblom A; Tahir M; Oduwole O; Jamaludin NA; Ravat S; Nikolova V; Chambers J; Selden C; Rees M; Marschall HU; Parker MG; Williamson C
Hepatology; 2013 Feb; 57(2):716-26. PubMed ID: 22961653
[TBL] [Abstract][Full Text] [Related]
6. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.
Chiang JY; Pathak P; Liu H; Donepudi A; Ferrell J; Boehme S
Dig Dis; 2017; 35(3):241-245. PubMed ID: 28249273
[TBL] [Abstract][Full Text] [Related]
8. Effect of maternal cholestasis on TGR5 expression in human and rat placenta at term.
Keitel V; Spomer L; Marin JJ; Williamson C; Geenes V; Kubitz R; Häussinger D; Macias RI
Placenta; 2013 Sep; 34(9):810-6. PubMed ID: 23849932
[TBL] [Abstract][Full Text] [Related]
9. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.
Chiang JYL; Ferrell JM
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G554-G573. PubMed ID: 31984784
[TBL] [Abstract][Full Text] [Related]
10. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy.
Van Mil SW; Milona A; Dixon PH; Mullenbach R; Geenes VL; Chambers J; Shevchuk V; Moore GE; Lammert F; Glantz AG; Mattsson LA; Whittaker J; Parker MG; White R; Williamson C
Gastroenterology; 2007 Aug; 133(2):507-16. PubMed ID: 17681172
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptors, bile acids and cholesterol homeostasis series - bile acids and pregnancy.
Abu-Hayyeh S; Papacleovoulou G; Williamson C
Mol Cell Endocrinol; 2013 Apr; 368(1-2):120-8. PubMed ID: 23159988
[TBL] [Abstract][Full Text] [Related]
12. Progesterone metabolites as farnesoid X receptor inhibitors.
Abu-Hayyeh S; Williamson C
Dig Dis; 2015; 33(3):300-6. PubMed ID: 26045261
[TBL] [Abstract][Full Text] [Related]
13. Role of macrophages in bile acid-induced inflammatory response of fetal lung during maternal cholestasis.
Herraez E; Lozano E; Poli E; Keitel V; De Luca D; Williamson C; Marin JJ; Macias RI
J Mol Med (Berl); 2014 Apr; 92(4):359-72. PubMed ID: 24317353
[TBL] [Abstract][Full Text] [Related]
14. Bile acid receptors in non-alcoholic fatty liver disease.
Li Y; Jadhav K; Zhang Y
Biochem Pharmacol; 2013 Dec; 86(11):1517-24. PubMed ID: 23988487
[TBL] [Abstract][Full Text] [Related]
15. Digestive physiology of the pig symposium: intestinal bile acid sensing is linked to key endocrine and metabolic signaling pathways.
Burrin D; Stoll B; Moore D
J Anim Sci; 2013 May; 91(5):1991-2000. PubMed ID: 23729782
[TBL] [Abstract][Full Text] [Related]
16. New insights in the multiple roles of bile acids and their signaling pathways in metabolic control.
de Boer JF; Bloks VW; Verkade E; Heiner-Fokkema MR; Kuipers F
Curr Opin Lipidol; 2018 Jun; 29(3):194-202. PubMed ID: 29553998
[TBL] [Abstract][Full Text] [Related]
17. Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology.
Brønden A; Knop FK
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31630179
[TBL] [Abstract][Full Text] [Related]
18. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.
Fiorucci S; Mencarelli A; Palladino G; Cipriani S
Trends Pharmacol Sci; 2009 Nov; 30(11):570-80. PubMed ID: 19758712
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptors, gestational metabolism and maternal metabolic disorders.
Manna LB; Williamson C
Mol Aspects Med; 2021 Apr; 78():100941. PubMed ID: 33455843
[TBL] [Abstract][Full Text] [Related]
20. [Effects of farnesoid X receptor ligand on the metabolism of bile acids in rats with estrogen-induced intrahepatic cholestasis of pregnancy].
Zou SL; Liu J; Lan Y; Cheng H; Gan XL
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):383-6. PubMed ID: 18510855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
